Table 2.
Incremental Cost (US dollars) of Technologies Designed to Improve Transfusion Safety
| Adverse event | Technology solution | Incremental cost/U |
|---|---|---|
| IBCT or ABO mistransfusion | PPI technologies (bar coding, RFID), check-type (second sample) policies | <$20 |
| Acute or delayed alloimmune hemolytic transfusion reactions | Database unification, definitive genotyping | <$10 |
| TRALI | HLA antibody screening | <$2 |
| Transfusion-transmitted infection, bacterial or viral | Pathogen reduction technology | >$100 |
Abbreviations: IBCT, incorrect blood component transfused; PPI, positive patient identification; RFID, radiofrequency identification; TRALI, transfusion-related acute lung injury; HLA, human leukocyte antigen.